Statins reduce risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia
In a cohort study conducted among 37 894 Taiwanese patients with type 2 diabetes and dyslipidemia, those taking statins had a lower rate of diabetic retinopathy and need for treatments for vision-threatening diabetic retinopathy than those not taking statins. When treatment was required, patients taking statins needed a smaller number of interventions than patients not taking statins. These findings are published online in JAMA Ophthalmology online Jan. 10,
To continue reading this article
Continue reading your article with a eMediNexus account.